Gsk (GSK) Long-Term Deferred Tax (2009 - 2026)
Gsk (GSK) posted quarterly Long-Term Deferred Tax of $8.5 billion for Q2 2026, down 3.13% year-over-year from $8.8 billion in Q2 2025, and little changed quarter-over-quarter from $8.5 billion in Q1 2026.
Gsk (GSK) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Gsk's Long-Term Deferred Tax history runs 18 years deep, the most recent figure standing at $8.5 billion for Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 3.13% year-over-year to $8.5 billion; the TTM figure through Jun 2026 stood at $8.5 billion (down 3.13% YoY), while the FY2025 annual figure was $8.6 billion, changed 0.47% from the prior year.
- Long-Term Deferred Tax for Q2 2026 stood at $8.5 billion, roughly flat from $8.5 billion in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $8.8 billion in Q2 2025, with the low at $421.3 million in Q1 2022.
- The 5-year median for Long-Term Deferred Tax is $7.6 billion (2023), against an average of $7.3 billion.
- The sharpest annual moves came in 2022 and 2023: Long-Term Deferred Tax plunged 92.91% in 2022, then surged 1518.42% in 2023.
- Gsk's Long-Term Deferred Tax stood at $6.6 billion in 2022, then rose by 13.13% to $7.5 billion in 2023, then increased by 15.52% to $8.7 billion in 2024, then rose by 0.0% to $8.7 billion in 2025, then dropped by 1.93% to $8.5 billion in 2026.
- Business Quant data shows GSK's Long-Term Deferred Tax at $8.5 billion in Q2 2026, $8.5 billion in Q1 2026, and $8.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.50 Bn |
| Mar 31, 2026 | 8.50 Bn |
| Dec 31, 2025 | 8.67 Bn |
| Sep 30, 2025 | 8.32 Bn |
| Jun 30, 2025 | 8.78 Bn |
| Mar 31, 2025 | 8.07 Bn |
| Dec 31, 2024 | 8.67 Bn |
| Sep 30, 2024 | 8.17 Bn |
| Jun 30, 2024 | 7.78 Bn |
| Mar 31, 2024 | 7.44 Bn |
| Dec 31, 2023 | 7.51 Bn |
| Sep 30, 2023 | 7.11 Bn |
| Jun 30, 2023 | 7.26 Bn |
| Mar 31, 2023 | 6.82 Bn |
| Dec 31, 2022 | 6.64 Bn |
| Sep 30, 2022 | 5.68 Bn |
| Jun 30, 2022 | 6.24 Bn |
| Mar 31, 2022 | 421.34 Mn |
| Dec 31, 2021 | 7.03 Bn |
| Sep 30, 2021 | 6.72 Bn |